ICICI Prudential Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $522K | Buy |
7,469
+1
| +0% | +$70 | 0.07% | 134 |
|
|
2025
Q1 | $549K | Sell |
7,468
-115
| -2% | -$8.45K | 0.07% | 129 |
|
|
2024
Q4 | $497K | Sell |
7,583
-18
| -0.2% | -$1.18K | 0.05% | 142 |
|
|
2024
Q3 | $592K | Buy |
7,601
+1,205
| +19% | +$93.9K | 0.06% | 127 |
|
|
2024
Q2 | $499K | Buy |
6,396
+599
| +10% | +$46.7K | 0.06% | 125 |
|
|
2024
Q1 | $393K | Buy |
5,797
+146
| +3% | +$9.89K | 0.04% | 140 |
|
|
2023
Q4 | $381K | Buy |
5,651
+468
| +9% | +$31.5K | 0.04% | 128 |
|
|
2023
Q3 | $351K | Buy |
5,183
+1,159
| +29% | +$78.5K | 0.05% | 125 |
|
|
2023
Q2 | $288K | Buy |
4,024
+164
| +4% | +$11.7K | 0.04% | 124 |
|
|
2023
Q1 | $268K | Buy |
3,860
+792
| +26% | +$55K | 0.04% | 115 |
|
|
2022
Q4 | $208K | Buy |
3,068
+895
| +41% | +$60.7K | 0.03% | 111 |
|
|
2022
Q3 | $119K | Buy |
2,173
+450
| +26% | +$24.6K | 0.02% | 120 |
|
|
2022
Q2 | $115K | Buy |
1,723
+83
| +5% | +$5.54K | 0.02% | 115 |
|
|
2022
Q1 | $110K | Buy |
+1,640
| New | +$110K | 0.01% | 124 |
|